Peer Review History
| Original SubmissionMay 24, 2020 |
|---|
|
PONE-D-20-15564 Time-series transcriptomic analysis reveals novel gene modules that controls theanine biosynthesis in tea plant (Camellia sinensis) PLOS ONE Dear Dr. zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 14 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Tapan Kumar Mondal, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ Additional Editor Comments (if provided): I am agree with the reviewer comments. You are encourage to resubmit the manuscript addressing all the poisnt. Also cite some of the classical paper of tea in the related tolpic. Some of them are: Mondal et al., 2004. Plant Cell Tissue Org Cult, 75: 795-856. and Mukhopadhyay et al., (2016) Plant Cell Rep 35(2):255-87 [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Major comments: Role of EA should be well mentioned in Introduction. Line 90- What is meant by sun exposed water? Line 101-102: One bud and one leaf refers to which leaf (seedling day, young/old, size etc) that should be mentioned. In Thea young leaf should have more theine and this leaf should be consistent in all experiments. Line 191-192: Number of DEGs decreased and increased after 9 days and 24 days of EA treatment. sentence not clear Line 248-251: It is not clear why there are different sets of hub and module connecting genes. It appears as if these are created to align the different functional module. A clear and simple explanation is needed to describe Figure 2. There should be one paragraph outlining the functions of these genes in thea pathway and a possible flowchart of heir interaction leading to thea biosynthesis. It is not clear from the network depicted. Line 261-264: Author has reported that the thea content on EA activation consistently increased from 3rd day to 24th day with 12 th day as turning point. Then he said thea content decreased during the whole EA treatment. Explain your sentence. In Discussion section, there is no detailing of HPLC and expression studies performed. Minor comments: Figure 1 and Figure 3 – Poor resolution and the legends within figure are not clear (eg. theanine content). Line 91-92 : Detail or Reference of nutritional medium should be provided. Line 163, 174: Thea and Theanine have been used randomly and in overlapping manner. It is better to stick to one annotation. Reviewer #2: The present work is well formulated but the design and execution of the experiment is needed to improve and to be more specifically the metabolic pathway enrichment analysis of theanine biosynthesis in tea plants that would be technically sound and novel approach. Some of the remarks I have listed below for improving the paper. Major remarks: 1) ‘The tea cutting seedlings in group I were used 96 as control and cultivated maintaining the original nutrition solution, while those in the 97 group II were cultivated using the same solution with the addition of 25mM EA 98 aqueous solution to their roots’. How you standardized the concentration of ethylamine (EA) treatment that activated thea pathway? 2) The discussion is too descriptive. The authors did not explain how the differences in EA dependent thea accumulation in tea plant may influence the observed changes in the transcript. 3) For transcriptomics-‘Total RNA was extracted from the samples using the RNA Prep Pure Plant Kit 106 (TianGen, Shanghai, China). The integrity and quality of RNA was measured using 107 gel electrophoresis (Thermo Scientific, Waltham, MA, USA) and a NanoDrop-2000 108 spectrophotometer (NanoDrop, Wilmington, DE, USA)’. For real time PCR- RNA samples were isolated from samples using our previous CTAB method [34].’Why the methods of RNA extraction are different for transcriptomics study and its validation by Real time PCR? Very few genes have been selected for the validation of transcriptomics. Validation of transcriptomics with some more genes are advisable. 4) ‘The housekeeping gene glyceraldehyde-3-phosphate 179 dehydrogenase (GAPDH) was used as an internal reference gene, and the relative 180 expression of genes was calculated using the ΔCT method’. However, it is advisable to use at least 2 or 3 reference genes for achieving accurate normalization. 5) Statistical analysis used here should be more descriptive in method section. 6) Alignment information of sequencing reads and assembly statistics of transcriptome were not discussed and not presented in the table. 7) It is not clear from experiments whether genes like CsBCS-1, CsRP, CsABC2 are regulated by EA treatment or by the accumulation of Thea in plant cell. Interaction between differentially expressed genes should be validated by more than one tool. 8) It would be better to validate the expression of some of the genes by checking the expression of proteins by Western blotting. 9) Fig. 1 in the GO functional enrichment analysis for upregulated (A) and downregulated genes which shown is not clearly visible. Clear Fig. advisable here which represents upregulated (A) and downregulated genes. 10) In Fig. 3 significant difference in expression of a particular gene between control and treated samples are not indicated properly. It is also advised clear fig. Other remarks: 11) Line no. 73-85 in Introduction section need to change and modify by describing the main aim/objectives of the present study Time-series transcriptomic analysis for theanine biosynthesis in tea plant. Do not present the results in this section. 12) Number of biological replicates of each sample (Control and treated) for transcriptomics are not clear in the method section? 13) The font size of all the figures are not clearly visible. 14) It is important to mention and elaborated description of 3-4 important categories of differentially expressed genes. 15) Line 2 Camellia sinensis should be Italic 16) Line no. 97 EA abbreviation required 17) Line no. 124 Shigeki is repeated 18) Reference no. 26 Journal name, vol. and page no. not mentioned 19) Reference no. 24, 40 and 45 need to correct 20) Scientific name written wherever in reference or main body, make it in italic 21) Line 291-293 is not clear. 22) Line no. 293-296 should be in result section 23) Line no. 321 should be upregulated instead of unregulated 24) The conclusion is not so clear. 25) The grammatical and typing errors should be corrected. Reviewer #3: There is no mention of the submission of RNA seq data in public databases. Please provide the SRA accession of submission in the manuscript. Provide better quality figure. Also comment on other metabolic pathways which get activated with the treatment of EA. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr. Bimal Das Reviewer #3: Yes: Atul Kumar Upadhyay [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Time-series transcriptomic analysis reveals novel gene modules that controls theanine biosynthesis in tea plant (Camellia sinensis) PONE-D-20-15564R1 Dear Dr. zhang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tapan Kumar Mondal, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): The paper is written well and hence can be accepted. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors described well all the previous suggested remarks and changed the manuscripts wherever required but it is advisable again to present high resolution Fig. 1, so that it can be clearly readable. Reviewer #3: The authors have carefully dealt with the issues raised by the reviewers. Thank you. I recommend for the publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr. Bimal Das Reviewer #3: Yes: Atul Kumar Upadhyay |
| Formally Accepted |
|
PONE-D-20-15564R1 Time-series transcriptomic analysis reveals novel gene modules that control theanine biosynthesis in tea plant (Camellia sinensis) Dear Dr. zhang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tapan Kumar Mondal Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .